TABLE 1.
Antibiotic use by patients at risk for ARE acquisition
| Antibiotic | No. of patients | No. of days |
|---|---|---|
| Antibiotics active in the intestinal compartment | ||
| Oral | ||
| Amoxicillin | 3 | 12 |
| Amoxicillin-clavulanic acid | 38 | 204 |
| Azithromycin | 2 | 6 |
| Ciprofloxacin | 41 | 279 |
| Clarithromycin | 1 | 5 |
| Clindamycin | 2 | 13 |
| Cotrimoxazol | 42 | 361 |
| Erythromycin | 3 | 24 |
| Norfloxacin | 4 | 45 |
| Tetracycline | 2 | 20 |
| Trimethoprim | 5 | 26 |
| Vancomycina | 1 | 6 |
| Flucloxacillin | 2 | 7 |
| Intraperitoneal | ||
| Cefazolin | 1 | 3 |
| Cephalothin | 1 | 2 |
| Intravenous | ||
| Amoxicillin | 3 | 10 |
| Amoxicillin-clavulanic acid | 48 | 237 |
| Cefazolin | 4 | 5 |
| Cefotaxime | 1 | 7 |
| Ceftazidime | 1 | 8 |
| Ceftriaxone | 61 | 403 |
| Ciprofloxacin | 6 | 11 |
| Erythromycin | 2 | 6 |
| Meropenem | 5 | 36 |
| Metronidazole | 2 | 2 |
| Piperacillina | 1 | 2 |
| Piperacillin-tazobactama | 4 | 21 |
| Antibiotics without activity in the intestinal compartment | ||
| Intraperitoneal | ||
| Vancomycin | 1 | 5 |
| Intravenous | ||
| Cefuroxime | 7 | 7 |
| Gentamicin | 20 | 35 |
| Vancomycin | 2 | 5 |
| Benzylpenicillin | 1 | 29 |
| Flucloxacillin | 5 | 27 |
a
Antibiotics active against ARE in the intestinal compartment.